Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The benefit of current stem cell transplantation therapy for myocardial infarction is limited by low survival rate for stem cell. The purpose of this study is to test whether intensive Atorvastatin therapy can improve the outcome of patients with impaired left ventricle function after myocardial infarction who underwent intracoronary transfer of autologous bone marrow cells.
Epistemonikos ID: b7d9c307d34ff0248c6ca607ce13314b2fabbbf3
First added on: May 05, 2024